Pharmaceutical Security

The Pharmaceutical Security Institute (PSI), established in 2002 by security directors from fourteen major pharmaceutical companies, focuses on combating the global threat of counterfeit medicinal products that endanger patient health and safety. With over forty member manufacturers from various nations, PSI works to improve information sharing and coordinate international inquiries to address the challenges posed by counterfeit drugs.

Operating from its headquarters in Vienna, VA, and with additional offices in Singapore and Dublin, PSI emphasizes the importance of strong anti-counterfeiting measures in regions where regulatory frameworks are weak. Membership is exclusive to major international pharmaceutical manufacturers committed to PSI's mission, ensuring a collective effort in the fight against counterfeit pharmaceuticals.

Generated from the website